Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 7 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2020 Filed Feb 19, 2020 20:39 UTC |
Shelton David CSVP, GC & Corp. Secretary
|
Tax withholdingCommon Stock | 5,516 | $19.37 | $106,844.92 |
DisclosureSEC source: 0001627223-20-000007 · primary_doc.xml · nonDerivative · entry 2 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,152 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:39 UTC |
Shelton David CSVP, GC & Corp. Secretary
|
GrantCommon Stock | 16,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000007 · primary_doc.xml · nonDerivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,668 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 18:54 UTC |
Vergnano MarkDirector · President and CEO
|
Tax withholdingCommon Stock | 56,086 | $19.37 | $1,086,385.82 |
DisclosureSEC source: 0001627223-20-000005 · primary_doc.xml · nonDerivative · entry 2 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,353 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 18:54 UTC |
Vergnano MarkDirector · President and CEO
|
GrantCommon Stock | 120,261 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000005 · primary_doc.xml · nonDerivative · entry 1 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,439 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 19:34 UTC |
Newman MarkSenior VP & COO
|
Tax withholdingCommon Stock | 9,656 | $19.37 | $187,036.72 |
DisclosureSEC source: 0001627223-20-000006 · primary_doc.xml · nonDerivative · entry 2 Newman Mark · CIK 0001524597 · Senior VP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,844 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 19:34 UTC |
Newman MarkSenior VP & COO
|
GrantCommon Stock | 26,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000006 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,500 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:32 UTC |
Kelliher Susan M.SVP, People & Health Services
|
Tax withholdingCommon Stock | 2,626 | $19.37 | $50,865.62 |
DisclosureSEC source: 0001627223-20-000010 · primary_doc.xml · nonDerivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,182 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:32 UTC |
Kelliher Susan M.SVP, People & Health Services
|
GrantCommon Stock | 7,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000010 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,808 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:53 UTC |
Ralhan SameerSVP, CFO & Treasurer
|
Tax withholdingCommon Stock | 2,002 | $19.37 | $38,778.74 |
DisclosureSEC source: 0001627223-20-000011 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,137 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:53 UTC |
Ralhan SameerSVP, CFO & Treasurer
|
GrantCommon Stock | 5,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000011 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,139 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:08 UTC |
Parker ErichSVP Corp Communications & CBO
|
Tax withholdingCommon Stock | 2,111 | $19.37 | $40,890.07 |
DisclosureSEC source: 0001627223-20-000009 · primary_doc.xml · nonDerivative · entry 2 Parker Erich · CIK 0001645203 · SVP Corp Communications & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,890 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:08 UTC |
Parker ErichSVP Corp Communications & CBO
|
GrantCommon Stock | 5,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000009 · primary_doc.xml · nonDerivative · entry 1 Parker Erich · CIK 0001645203 · SVP Corp Communications & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,001 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 20:06 UTC |
Vergnano MarkDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 220,759 | $0.00 Strike: $11.87 | $0.00 |
DisclosureSEC source: 0001627223-20-000003 · primary_doc.xml · derivative · entry 4 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 220,759 shares Expires 2020-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 was effected pursuant to a previously reported Rule 10b5-1 trading plan. F3 · derivative.exercise_date: These options were issued to the reporting person while he was employed by DuPont and were converted to Chemours options in connection with the Company's separation from DuPont. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 20:06 UTC |
Vergnano MarkDirector · President and CEO
|
SaleCommon Stock | 220,759 | $16.00 | $3,532,673.82 |
DisclosureSEC source: 0001627223-20-000003 · primary_doc.xml · nonDerivative · entry 2 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,178 F1 · kind: The stock option exercise and sale reported in this Form 4 was effected pursuant to a previously reported Rule 10b5-1 trading plan. F2 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $15.365 to $16.36. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 20:06 UTC |
Vergnano MarkDirector · President and CEO
|
Exercise / conversionCommon Stock | 220,759 | $11.87 | $2,620,254.80 |
DisclosureSEC source: 0001627223-20-000003 · primary_doc.xml · nonDerivative · entry 1 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 was effected pursuant to a previously reported Rule 10b5-1 trading plan. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 20:01 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 1,509 | $18.09 | $27,297.81 |
DisclosureSEC source: 0001627223-20-000001 · primary_doc.xml · derivative · entry 2 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,811 Underlying: Common Stock · 1,509 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 20:20 UTC |
BELL BRADLEY JDirector
|
GrantStock Units · Derivative | 1,326 | $18.09 | $23,987.34 |
DisclosureSEC source: 0001627223-20-000002 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,657 Underlying: Common Stock · 1,326 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:57 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 1,827.3092 | $14.94 | $27,300.00 |
DisclosureSEC source: 0001627223-19-000051 · primary_doc.xml · derivative · entry 2 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,873.4534 Underlying: Common Stock · 1,827.3092 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:39 UTC |
BELL BRADLEY JDirector
|
GrantStock Units · Derivative | 1,606.4257 | $14.94 | $24,000.00 |
DisclosureSEC source: 0001627223-19-000050 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,283.2438 Underlying: Common Stock · 1,606.4257 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| September 11, 2019 Filed Sep 13, 2019 21:48 UTC |
Newman MarkSenior VP & COO
|
PurchaseCommon Stock | 20,000 | $16.42 | $328,340.00 |
DisclosureSEC source: 0001627223-19-000049 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,261 Read SEC document |
| August 07, 2019 Filed Aug 9, 2019 01:44 UTC |
CRANSTON MARY BDirector
|
PurchaseCommon Stock | 1,790 | $13.99 | $25,042.10 |
DisclosureSEC source: 0001627223-19-000047 · primary_doc.xml · nonDerivative · entry 1 CRANSTON MARY B · CIK 0001104268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,018 F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| August 06, 2019 Filed Aug 6, 2019 21:20 UTC |
Snell E BryanPresident - Titanium Tech
|
PurchaseCommon Stock | 12,000 | $13.77 | $165,240.00 |
DisclosureSEC source: 0001627223-19-000045 · primary_doc.xml · nonDerivative · entry 1 Snell E Bryan · CIK 0001645180 · President - Titanium Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,774 Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 00:48 UTC |
ANASTASIO CURTDirector
|
PurchaseCommon Stock | 3,500 | $14.15 | $49,525.00 |
DisclosureSEC source: 0001627223-19-000043 · primary_doc.xml · nonDerivative · entry 1 ANASTASIO CURT · CIK 0001032097 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,500 Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 21:40 UTC |
Shelton David CSVP, GC & Corp. Secretary
|
PurchaseCommon Stock | 15,000 | $13.82 | $207,256.50 |
DisclosureSEC source: 0001627223-19-000046 · primary_doc.xml · nonDerivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,269 F1 · price: Price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $13.80 to $13.84. Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 21:06 UTC |
BELL BRADLEY JDirector
|
PurchaseCommon Stock | 5,000 | $14.67 | $73,350.00 |
DisclosureSEC source: 0001627223-19-000044 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 20,400 Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:57 UTC |
Kane Erin NDirector
|
GrantCommon Stock | 7,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000042 · primary_doc.xml · nonDerivative · entry 1 Kane Erin N · CIK 0001684077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,603 Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:25 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 1,137.5 | $24.00 | $27,300.00 |
DisclosureSEC source: 0001627223-19-000040 · primary_doc.xml · derivative · entry 1 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,366.5 Underlying: Common Stock · 1,137.5 shares Expires not disclosed F1 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · derivative.exercise_date: Payable upon separation from service. F2 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:45 UTC |
BELL BRADLEY JDirector
|
GrantStock Units · Derivative | 1,000 | $24.00 | $24,000.00 |
DisclosureSEC source: 0001627223-19-000041 · primary_doc.xml · derivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652 Underlying: Common Stock · 1,000 shares Expires not disclosed F1 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · derivative.exercise_date: Payable upon separation from service. F2 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| June 10, 2019 Filed Jun 10, 2019 21:57 UTC |
Vergnano MarkDirector · President and CEO
|
PurchaseCommon Stock | 44,000 | $23.17 | $1,019,466.80 |
DisclosureSEC source: 0001627223-19-000037 · primary_doc.xml · nonDerivative · entry 1 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,600 F1 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $22.86 to $23.35. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 06:40 UTC Amendment |
Vergnano MarkDirector · President and CEO
|
PurchaseCommon Stock | 44,000 | $23.17 | $1,019,466.80 |
DisclosureSEC source: 0001627223-19-000038 · primary_doc.xml · nonDerivative · entry 1 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,600 F1 · price: Price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $22.86 to $23.35. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 15:51 UTC |
Sparks Edwin CPresident - Chemical Solutions
|
GrantStock Option (Right to Buy) · Derivative | 17,830 | $0.00 Strike: $21.96 | $0.00 |
DisclosureSEC source: 0001627223-19-000034 · primary_doc.xml · derivative · entry 1 Sparks Edwin C · CIK 0001735771 · President - Chemical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,830 Underlying: Common Stock · 17,830 shares Expires 2029-06-03 Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 15:39 UTC |
Newman MarkSenior VP & COO
|
GrantStock Option (Right to Buy) · Derivative | 29,717 | $0.00 Strike: $21.96 | $0.00 |
DisclosureSEC source: 0001627223-19-000033 · primary_doc.xml · derivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,717 Underlying: Common Stock · 29,717 shares Expires 2029-06-03 Read SEC document |
| June 03, 2019 Filed Jun 6, 2019 01:16 UTC |
Ralhan SameerSVP, CFO & Treasurer
|
GrantStock Option (Right to Buy) · Derivative | 17,830 | $0.00 Strike: $21.96 | $0.00 |
DisclosureSEC source: 0001627223-19-000036 · primary_doc.xml · derivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,830 Underlying: Common Stock · 17,830 shares Expires 2029-06-03 Read SEC document |
| May 17, 2019 Filed May 20, 2019 21:59 UTC |
Kelliher Susan M.SVP, People & Health Services
|
PurchaseCommon Stock | 6,500 | $23.06 | $149,878.30 |
DisclosureSEC source: 0001627223-19-000032 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,693 F1 · price: Price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $23.04 to $23.10. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| May 16, 2019 Filed May 21, 2019 01:05 UTC |
CRANSTON MARY BDirector
|
PurchaseCommon Stock | 1,044 | $23.91 | $24,965.90 |
DisclosureSEC source: 0001627223-19-000031 · primary_doc.xml · nonDerivative · entry 1 CRANSTON MARY B · CIK 0001104268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,883 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:29 UTC |
BELL BRADLEY JDirector
|
PurchaseCommon Stock | 5,000 | $24.06 | $120,300.00 |
DisclosureSEC source: 0001627223-19-000030 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,400 Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:52 UTC |
CRAWFORD CURTIS JDirector
|
GrantCommon Stock | 4,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000027 · primary_doc.xml · nonDerivative · entry 1 CRAWFORD CURTIS J · CIK 0001014318 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,979 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| May 01, 2019 Filed May 3, 2019 19:18 UTC |
ANASTASIO CURTDirector
|
GrantCommon Stock | 4,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000023 · primary_doc.xml · nonDerivative · entry 1 ANASTASIO CURT · CIK 0001032097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,780 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| May 01, 2019 Filed May 3, 2019 23:55 UTC |
CRANSTON MARY BDirector
|
GrantCommon Stock | 4,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000026 · primary_doc.xml · nonDerivative · entry 1 CRANSTON MARY B · CIK 0001104268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,839 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| May 01, 2019 Filed May 3, 2019 16:02 UTC |
BROWN RICHARD HDirector
|
GrantCommon Stock | 4,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000025 · primary_doc.xml · nonDerivative · entry 1 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,449 F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| May 01, 2019 Filed May 4, 2019 01:19 UTC |
Keohane Sean DDirector
|
GrantCommon Stock | 4,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000029 · primary_doc.xml · nonDerivative · entry 1 Keohane Sean D · CIK 0001435737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,916 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| May 01, 2019 Filed May 3, 2019 15:40 UTC |
BELL BRADLEY JDirector
|
GrantCommon Stock | 4,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000024 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,839 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| May 01, 2019 Filed May 4, 2019 01:01 UTC |
Farrell Dawn LDirector
|
GrantCommon Stock | 4,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000028 · primary_doc.xml · nonDerivative · entry 1 Farrell Dawn L · CIK 0001645639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,839 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 21:47 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 734.66 | $37.16 | $27,299.97 |
DisclosureSEC source: 0001627223-19-000022 · primary_doc.xml · derivative · entry 2 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,229 Underlying: Common Stock · 734.66 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · shares: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| March 29, 2019 Filed May 3, 2019 15:40 UTC |
BELL BRADLEY JDirector
|
GrantStock Units · Derivative | 645.8557 | $37.16 | $24,000.00 |
DisclosureSEC source: 0001627223-19-000024 · primary_doc.xml · derivative · entry 2 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 645.8557 Underlying: Common Stock · 645.8557 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service in five annual installments. F3 · derivative.expiration_date: Payable upon separation from service in five annual installments. Read SEC document |
| March 15, 2019 Filed Mar 15, 2019 18:50 UTC |
Trojanowski AmyVP and Controller
|
SaleCommon Stock | 9,049 | $39.10 | $353,815.90 |
DisclosureSEC source: 0001627223-19-000021 · primary_doc.xml · nonDerivative · entry 2 Trojanowski Amy · CIK 0001645181 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,746 F1 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $39.05 to $39.17. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 18:50 UTC |
Trojanowski AmyVP and Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,049 | $0.00 Strike: $15.49 | $0.00 |
DisclosureSEC source: 0001627223-19-000021 · primary_doc.xml · derivative · entry 4 Trojanowski Amy · CIK 0001645181 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,049 shares Expires 2021-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options are fully exercisable. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 18:50 UTC |
Trojanowski AmyVP and Controller
|
SaleCommon Stock | 1,080 | $39.10 | $42,228.00 |
DisclosureSEC source: 0001627223-19-000021 · primary_doc.xml · nonDerivative · entry 3 Trojanowski Amy · CIK 0001645181 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,666 F2 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $39.10 to $39.12. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 18:50 UTC |
Trojanowski AmyVP and Controller
|
Exercise / conversionCommon Stock | 9,049 | $15.49 | $140,142.77 |
DisclosureSEC source: 0001627223-19-000021 · primary_doc.xml · nonDerivative · entry 1 Trojanowski Amy · CIK 0001645181 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 21:51 UTC |
Newman MarkSenior VP and CFO
|
SaleCommon Stock | 59,210 | $38.26 | $2,265,374.60 |
DisclosureSEC source: 0001627223-19-000019 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,261 F1 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $38.16 to $38.40. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.